Entera Bio ENTX Cash Flow Statement (2019-2026)

NASDAQ ENTX
$3.01 -0.01 (-0.33%)
As of: Oct 21, 2026 · 1:16 PM EDT
Reported Financials

Entera Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Entera Bio reported cash from operations of -$3.46M and free cash flow of -$3.47M for the quarter ended Jun 2026, down 112.4% year over year. This cash flow statement covers 26 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.02M-2.15M-3.02M-2.36M-2.57M-2.66M-3.20M-3.02M-3.51M-7.31M
Depreciation and DepletionDep. & Depletion
0.02M0.01M0.02M0.02M0.02M0.02M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.01M0.02M0.02M0.02M0.02M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp.
0.63M0.37M0.96M0.70M0.11M0.48M0.52M0.47M0.38M0.32M0.46M0.60M0.93M0.57M0.60M0.51M0.93M0.71M0.67M0.62M
Deferred Taxes
-0.06M-0.05M-0.03M-0.03M0.21M0.02M0.03M0.01M
Other non-cash itemsOther Non-Cash
0.00M0.02M-0.04M-0.03M0.00M0.00M0.00M0.00M-0.01M0.02M-0.01M-0.01M0.00M0.01M0.00M0.02M-0.03M0.04M0.01M2.77M
Change in Working Capital
Change in ReceivablesChange Receivables
0.14M-0.07M0.03M0.02M0.01M0.01M-0.22M-0.03M0.06M0.08M-0.01M
Change in Account PayablesChange Payables
0.04M-0.16M0.03M-0.09M0.30M-0.40M0.13M0.09M0.32M-0.48M-0.02M0.00M0.12M-0.05M0.00M0.25M-0.17M0.23M-0.17M0.30M
Change in Accured ExpensesChange Accured Exp.
0.23M1.10M-0.81M-0.58M-0.76M0.58M0.06M0.19M-0.15M-0.66M0.03M0.17M-0.31M0.31M0.89M0.03M-0.08M0.20M0.00M-0.02M
Change in Other Operating AssetsOther Assets Change
-0.40M-0.21M1.10M-0.40M-0.32M-0.34M0.36M0.00M-0.24M-0.17M0.32M-0.09M-0.19M-0.03M0.33M-0.08M-0.03M0.01M0.09M-0.05M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M0.02M-0.02M
Other Working Capital ChangesOther WC Changes
0.40M0.22M-1.11M0.40M0.32M0.34M-0.36M0.00M0.24M0.17M-0.32M0.09M0.19M0.03M-0.33M0.08M0.03M-0.01M-0.09M0.05M
Cash from OperationsCash from Ops.
-2.11M-2.51M-4.79M-2.83M-2.87M-2.01M-1.61M-1.56M-1.53M-2.62M-1.86M-1.34M-2.15M-1.47M-1.40M-1.63M-2.50M-1.83M-3.09M-3.46M
Investing Activities
Capital ExpendituresCapex
0.01M0.01M0.02M0.02M0.00M0.00M0.01M0.00M0.01M0.00M0.01M0.03M0.04M0.03M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.01M-0.02M-0.02M0.00M0.00M-0.01M0.00M-0.01M0.00M-0.01M-0.03M-0.04M-0.03M0.00M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.01M-0.02M-0.02M-0.06M0.00M-0.01M0.00M-0.01M0.00M-0.01M-0.03M-0.04M-0.03M0.00M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
2.59M0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.43M0.17M0.13M-0.13M
Net Shares Issued and RepurchasedNet Shares Issued
2.59M0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.43M0.17M0.13M-0.13M
Net Equity Issued and RepurchasedNet Equity Issued
2.59M0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.43M0.17M0.13M-0.13M
Other financing activitiesOther financing
-0.02M-0.30M-0.19M-0.08M0.00M-0.17M
Cash from Financing ActivitiesCash from Financing
2.59M0.02M0.01M0.01M6.03M0.03M1.22M0.01M3.22M13.34M-0.05M0.25M0.17M0.13M9.96M
Additional items
Exchange Rate EffectFX Effect
0.03M-0.07M0.00M0.02M
Change in Cash
0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.56M-1.53M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.30M-1.72M-2.96M6.49M
Ending Cash Balance
27.47M24.96M20.15M17.32M14.39M12.38M10.76M9.20M7.68M11.09M9.25M9.13M6.99M8.74M20.67M18.95M16.69M14.97M12.02M18.53M
Free Cash FlowFCF
-2.12M-2.52M-4.82M-2.85M-2.87M-2.01M-1.62M-1.56M-1.53M-2.62M-1.86M-1.34M-2.15M-1.47M-1.41M-1.66M-2.55M-1.86M-3.09M-3.47M
Net Cash FlowNCF
0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.56M-1.53M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.30M-1.69M-2.96M6.49M

Entera Bio Cash Flow Statement API

Pull Entera Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ENTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY